Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Ching-Ho

Ching-Ho Chang, Hsinchu City TW

Patent application numberDescriptionPublished
20110279150BUFFER OPERATIONAL AMPLIFIER WITH SELF-OFFSET COMPENSATOR AND EMBEDDED SEGMENTED DAC FOR IMPROVED LINEARITY LCD DRIVER - A driver utilizes selective biasing of the terminal of an operational amplifier to reduce offset in the operational amplifier output. Each operational amplifier input includes a differential input pair of transistors including a NMOS transistor and PMOS transistor. At low and high ends of the input voltage range these transistors are selectively and individually coupled to either a standard input or biased to be on so as to contribute offset for offset compensation. The transistors are biased in a conventional manner for input voltages between the low and high ends of the voltage range.11-17-2011

Ching-Ho Hsieh, Tainan City TW

Patent application numberDescriptionPublished
20110117195METHOD FOR IMPROVING MYOCARDIAL INFARCTION BY INTRAMYOCARDIAL OR TRANSENDOCARDIAL INJECTION OF PEPTIDE NANOFIBERS - A method for improving myocardial infarction by intramyocardial or transendocardial injection of peptide nanofibers is disclosed. The method firstly provides a pharmaceutical composition having a biologically compatible peptide hydrogel formed by a plurality of self-assembling peptide nanofibers and selectively having at least one type of autologous stem cells mixed with the self-assembling peptide nanofibers, and then the pharmaceutical composition is administered to an entire infarcted area of myocardium tissue with myocardial infarction by intramyocardial or transendocardial injection. Thus, adverse cardiac remodeling and dysfunction after acute infraction can be attenuated, while the therapeutic myocardial angiogenesis, the myocardial capillary density and potential myogenesis can be enhanced.05-19-2011

Ching-Ho Wang, Taipei TW

Patent application numberDescriptionPublished
20100048423SIMULTANEOUS DETECTION, DIFFERENTIATION AND TYPING SYSTEM OF NEWCASTLE DISEASE AND AVIAN INFLUENZA VIRUSES - A simultaneous detection, differentiation and typing system of Newcastle disease and avian influenza viruses is provided. The present invention provides a system, including an oligonucleotide microarray, avian virus specific probes is disposed on the oligonucleotide microarray and the avian viruses include Newcastle disease and avian influenza viruses, and avian virus nucleic acid products, hybridized with the avian virus specific probes on the oligonucleotide microarray. The present invention describes a fast, simultaneous and inexpensive approach to the detection of Newcastle disease virus (NDV) and avian influenza virus (AIV) and possesses good sensitivity and specificity among divergent viruses. The hybridization results on microarrays were clearly identified with the naked eyes, with no further imaging equipment needed. The present invention provides potential for rapid surveillance and differential diagnosis of these two important zoonoses in both wild and domestic birds.02-25-2010

Ching-Ho Wang, Taipei City TW

Patent application numberDescriptionPublished
20090073420Optical waveguide surface plasmon resonance sensor - An optical waveguide SPR sensor is adapted for differential measurement. The optical waveguide SPR sensor includes a base, a bottom layer, and at least one set of optical waveguide layers. The set of the optical waveguide layers includes a measuring optical waveguide channel and a reference optical waveguide channel. The measuring optical waveguide channel includes an SPR sensing film layer. The measuring optical waveguide channel and the reference optical waveguide channel are independently configured and substantially parallel one to another. The bottom layer has a refractive index higher than a refractive index of the optical waveguide layer.03-19-2009

Ching-Ho Yang, Hsinchu City TW

Patent application numberDescriptionPublished
20090108348SEMICONDUCTOR DEVICE - A semiconductor device is provided. An isolation structure is formed in a substrate to define a first and a second active region, and a channel active region therebetween. A field implant region is formed below a portion of the isolation structure around the first, second, and channel active regions. A channel active region includes two first sides defining a channel width. The distance from each first side to a second side of a neighboring field implant region is d04-30-2009